Isaksson M, Bruze M, Lepoittevin J P, Goossens A
Department of Occupational and Environmental Dermatology, Malmö University Hospital, Malmö, Sweden.
Am J Contact Dermat. 2001 Sep;12(3):170-6.
Budesonide, a marker for corticosteroid allergy, is a 1:1 mixture of 2 diastereomers, the R and S, present in all commercial formulations. Budesonide is said to cross-react with group B substances through the R and S diastereomer and some group D substances only through the S diastereomer.
To investigate the cross-reactivity pattern between the R and S diastereomers and 4 potentially cross-reacting substances, 2 from group B and 2 from group D.
By patch testing 10 patients hypersensitive to budesonide with a serial dilution of budesonide, the R and S diastereomer, triamcinolone acetonide, amcinonide, prednicarbate, and hydrocortisone-17-butyrate.
Nine of 10 patients reacted to budesonide and the S diastereomer. Seven of 9 to the R diastereomer. Each of the 9 patients with S diastereomer allergy reacted to the group B and/or group D substances. Five patients reacted to triamcinolone acetonide, not to 1.0% but only to 0.0010% and 0.00010%.
The R and S diastereomers can induce positive patch test reactions in budesonide-hypersensitive individuals. The potential of budesonide to cross-react with substances from group B and D might be explained by the presence of the 2 diastereomers. When patch testing with triamcinolone acetonide, much lower concentrations than recommended should be used.
布地奈德是一种皮质类固醇过敏标志物,是两种非对映异构体(R和S)的1:1混合物,存在于所有市售制剂中。据说布地奈德通过R和S非对映异构体与B组物质发生交叉反应,仅通过S非对映异构体与一些D组物质发生交叉反应。
研究R和S非对映异构体与4种潜在交叉反应物质(2种来自B组,2种来自D组)之间的交叉反应模式。
对10名对布地奈德过敏的患者进行斑贴试验,使用布地奈德、R和S非对映异构体、曲安奈德、安西奈德、泼尼卡酯和氢化可的松-17-丁酸酯的系列稀释液。
10名患者中有9名对布地奈德和S非对映异构体有反应。9名中有7名对R非对映异构体有反应。9名对S非对映异构体过敏的患者均对B组和/或D组物质有反应。5名患者对曲安奈德有反应,不是对1.0%,而是仅对0.0010%和0.00010%有反应。
R和S非对映异构体可在布地奈德过敏个体中诱导阳性斑贴试验反应。布地奈德与B组和D组物质发生交叉反应的可能性可能由这两种非对映异构体的存在来解释。用曲安奈德进行斑贴试验时,应使用比推荐浓度低得多的浓度。